XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia

Clinical trial NCT05038644 · TERMINATED

Trial details

NCT number: NCT05038644
Sponsor: Ehab L Atallah
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia T Cell Acute Lymphoblastic Leukemia T Cell Lymphoblastic Lymphoma

Start date: 2022-02-02
Primary completion: 2024-04-24
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.